Growth Metrics

Fulgent Genetics (FLGT) Short term Debt (2020 - 2026)

Fulgent Genetics' Short term Debt history spans 7 years, with the latest figure at $30.6 million for Q1 2026.

  • On a quarterly basis, Short term Debt rose 10.56% to $30.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $30.6 million, a 10.56% increase, with the full-year FY2025 number at $28.1 million, up 1.94% from a year prior.
  • Short term Debt hit $30.6 million in Q1 2026 for Fulgent Genetics, up from $28.1 million in the prior quarter.
  • Over the last five years, Short term Debt for FLGT hit a ceiling of $30.6 million in Q1 2026 and a floor of $10.9 million in Q4 2022.
  • Historically, Short term Debt has averaged $23.0 million across 5 years, with a median of $26.9 million in 2024.
  • Biggest five-year swings in Short term Debt: soared 4945.12% in 2022 and later tumbled 50.07% in 2023.
  • Tracing FLGT's Short term Debt over 5 years: stood at $10.9 million in 2022, then skyrocketed by 108.35% to $22.7 million in 2023, then grew by 21.63% to $27.6 million in 2024, then grew by 1.94% to $28.1 million in 2025, then rose by 8.79% to $30.6 million in 2026.
  • Business Quant data shows Short term Debt for FLGT at $30.6 million in Q1 2026, $28.1 million in Q4 2025, and $28.5 million in Q3 2025.